CODX
What one share of Co-Diagnostics holds
Surgical and Medical Instruments and Apparatus
Co-Diagnostics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.30 |
|---|---|
| Profit | −$19.36 |
| Capex (buildings and equipment) | $0.15 |
| Free cash flow | −$11.30 |
| Cash and investments | $0.75 |
| Book value | $2.61 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | −$5.85 | $0.04 | −$4.02 | — | −$9.09 |
| 2017 | — | −$19.05 | $0.35 | −$9.14 | — | $9.38 |
| 2018 | — | −$15.07 | $0.10 | −$9.90 | — | −$2.46 |
| 2019 | — | −$11.09 | $0.20 | −$10.09 | — | $3.01 |
| 2020 | $79.88 | $45.51 | $0.83 | $29.35 | — | $70.06 |
| 2021 | $98.20 | $36.78 | $0.67 | $40.54 | — | $119.29 |
| 2022 | $32.61 | −$13.57 | $1.36 | $4.90 | — | $111.28 |
| 2023 | $6.96 | −$36.12 | $1.40 | −$23.97 | — | $82.13 |
| 2024 | $3.87 | −$37.22 | $0.74 | −$29.57 | — | $48.90 |
| 2025 | $0.47 | −$35.25 | $0.53 | −$22.43 | — | $9.85 |